Condition
Retinal Diseases
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 5 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownDefining Retinal Structures Using Hyperspectral Retinal ImagingNCT07555574 · 2025-01-01
RECRUITINGAn Interpretable Fundus Diseases Report Generating System Based On Weakly LabelingsNCT06918028 · 2025-05-01
NOT_YET_RECRUITINGAssess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)NCT06011798 · 2023-08-23
COMPLETEDEvaluation of Diabetic Retinopathy Using Ultra-Widefield Fundus Images Compared With Two-Field Fundus ImagesNCT05836194 · 2022-10-01
COMPLETEDIntravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic RetinopathyNCT01746563 · 2011-05-01
COMPLETEDCommon interventions
Mapped drugs appearing in these trials
Shared trial participation only; not evidence of efficacy or approval.
Leading sponsors
Trial status mix
COMPLETED3
NOT_YET_RECRUITING1
RECRUITING1
Phase mix
PHASE22
NA1
PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.